Statement Of Changes In Equity [Abstract]

Pharming Group N.V. - Filing #2154299

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	218,781,000 USD	—	265,262,000 USD	2,057,000 USD	—	—	478,431,000 USD	—	7,669,000 USD	204,638,000 USD	—	—	—	—	8,737,000 USD	462,297,000 USD	256,431,000 USD	7,509,000 USD	—	273,167,000 USD	3,400,000 USD	192,916,000 USD	455,254,000 USD	7,429,000 USD
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	10,548,000 USD	—	— USD	—	—	10,548,000 USD	— USD	—	— USD	—	—	— USD	— USD	13,674,000 USD	13,674,000 USD	—	—	—	—	— USD	—	—	—	—	—
Other comprehensive income	7,103,000 USD	—	7,103,000 USD	—	—	— USD	— USD	—	— USD	—	—	— USD	11,054,000 USD	11,054,000 USD	— USD	—	—	—	—	— USD	—	—	—	—	—
Comprehensive income	3,445,000 USD	—	7,103,000 USD	—	—	10,548,000 USD	— USD	—	— USD	—	—	— USD	11,054,000 USD	2,620,000 USD	13,674,000 USD	—	—	—	—	— USD	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	9,251,000 USD	—	— USD	—	—	9,251,000 USD	— USD	—	— USD	—	—	— USD	— USD	6,392,000 USD	6,392,000 USD	—	—	—	—	— USD	—	—	—	—	—